Sofinnova Investments, Inc. Supernus Pharmaceuticals, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.47 Billion
- Q2 2025
A detailed history of Sofinnova Investments, Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 799,253 shares of SUPN stock, worth $33 Million. This represents 1.71% of its overall portfolio holdings.
Number of Shares
799,253
Previous 520,678
53.5%
Holding current value
$33 Million
Previous $17.1 Million
47.74%
% of portfolio
1.71%
Previous 1.26%
Shares
5 transactions
Others Institutions Holding SUPN
# of Institutions
311Shares Held
61.6MCall Options Held
11.4KPut Options Held
0-
Black Rock Inc. New York, NY10.4MShares$429 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.21MShares$256 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.81MShares$198 Million2.66% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$125 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.76MShares$114 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.21B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...